Here is a new company report on Atria from Pauli following the Q2 results 
Q2 strengthened our confidence in the company’s earnings growth through both the actual figures and the progress made in its strategy. The effects of cost inflation will intensify in H2, but we believe the company will be able to meet the challenge through, for example, pricing. The realization of the guidance, which assumes earnings growth, now appears very likely. The valuation is attractive for a stable earnings grower, so we reiterate our “accumulate” (lisää) recommendation and raise our target price to 19 euros, supported by forecast upgrades (previously €16).